MyFinsight
Home
Blog
About
Contact
Download
Download image
Commercial Supply
Agreement-United Therapeutics...
$102,385K
Amphastar-Co Promotion
Agreement
$2,000K
Cipla Ltd-License And
Distribution Agreement
$1,222K
License
Agreement-United Therapeutics...
$1,000K
Other Agreement
$106K
Royalty
$128,116K
Product
$114,137K
License And Service
$106,713K
Total revenues
$348,966K
Income from operations
$38,801K
Total expenses
$310,165K
Income tax (benefit)
expense
-$4,456K
Income before income
tax (benefit)...
$1,407K
Total other expense
-$37,394K
Interest income, net
$8,053K
Selling, general and
administrative
$144,135K
Research and development
$66,348K
Cost of revenue -
collaborations and...
$61,160K
Cost of goods sold -
commercial, excluding...
$26,800K
Loss (gain) on
foreign currency...
-$7,749K
Amortization of acquired
intangible assets
$3,973K
Consolidated net income
(loss)
$5,863K
Interest expense on
liability for sale of...
$14,449K
Interest expense
$13,830K
Interest expense on
financing liability
$9,750K
Impairment of
available-for-sale investment
$6,409K
Other (expense)
income
-$1,009K
Back
Back
Income Statement
source: myfinsight.com
MANNKIND CORP (MNKD)
MANNKIND CORP (MNKD)